Amphastar Pharmaceuticals AMPH Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's restricted cash?
- Amphastar Pharmaceuticals (AMPH) reported restricted cash of $235K in Q1 2026.
- How has Amphastar Pharmaceuticals's restricted cash changed year-over-year?
- Amphastar Pharmaceuticals's restricted cash decreased by 0.0% year-over-year, from $235K to $235K.
- What is the long-term trend for Amphastar Pharmaceuticals's restricted cash?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's restricted cash has grown at a -33.9% compound annual growth rate (CAGR), from $1.87M to $235K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.